This inventor holds 2 USPTO granted patents. Top assignees: Centre National De La Recherche Scientifique, Les Laboratoires Servier, University Claude Bernard - Lyon 1. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2012
Title: Riccardo Piccardi: Innovator in Pharmaceutical Chemistry
Introduction
Riccardo Piccardi is a notable inventor based in Antony, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of complex compounds. With a total of 2 patents to his name, Piccardi's work has implications for the development of important medications.
Latest Patents
Piccardi's latest patents include a process for the preparation of functionalised benzocyclobutenes, which has applications in the synthesis of ivabradine and its addition salts with pharmaceutically acceptable acids. Another patent focuses on the preparation of compounds of a specific formula, which also relates to ivabradine and its derivatives. These innovations highlight his expertise in creating valuable chemical processes that can enhance pharmaceutical development.
Career Highlights
Throughout his career, Piccardi has worked with esteemed organizations such as Les Laboratoires Servier and the Centre National de La Recherche Scientifique. His experience in these institutions has allowed him to refine his skills and contribute to significant advancements in pharmaceutical research.
Collaborations
Piccardi has collaborated with notable colleagues, including Jean-Louis Peglion and Olivier Baudoin. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of chemistry.
Conclusion
Riccardo Piccardi's contributions to pharmaceutical chemistry through his patents and collaborations demonstrate his commitment to advancing medical science. His work continues to influence the development of important therapeutic compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile